IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive: Mouse model systems, with a null mutation in IRF8 a myeloproliferative syndrome was observed with marked expansion of undifferentiated myeloid cells that can progress to significant and fatal blast crisis of human CML [39].